These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
214 related articles for article (PubMed ID: 27965386)
41. Multiple receptor-ligand based pharmacophore modeling and molecular docking to screen the selective inhibitors of matrix metalloproteinase-9 from natural products. Gao Q; Wang Y; Hou J; Yao Q; Zhang J J Comput Aided Mol Des; 2017 Jul; 31(7):625-641. PubMed ID: 28623487 [TBL] [Abstract][Full Text] [Related]
42. Structural evidence for a constrained conformation of short CDR-L3 in antibodies. Teplyakov A; Obmolova G; Malia TJ; Luo J; Gilliland GL Proteins; 2014 Aug; 82(8):1679-83. PubMed ID: 24470236 [TBL] [Abstract][Full Text] [Related]
43. Humanization of a murine monoclonal antibody by simultaneous optimization of framework and CDR residues. Wu H; Nie Y; Huse WD; Watkins JD J Mol Biol; 1999 Nov; 294(1):151-62. PubMed ID: 10556035 [TBL] [Abstract][Full Text] [Related]
44. An antibody loop replacement design feasibility study and a loop-swapped dimer structure. Clark LA; Boriack-Sjodin PA; Day E; Eldredge J; Fitch C; Jarpe M; Miller S; Li Y; Simon K; van Vlijmen HW Protein Eng Des Sel; 2009 Feb; 22(2):93-101. PubMed ID: 19074157 [TBL] [Abstract][Full Text] [Related]
48. Initial repertoire of anti-(4-hydroxy-3-nitrophenylacetyl) antibodies as potential donors for effective affinity maturation. Furukawa K; Manabe A; Furukawa A; Kuba H; Okajima T; Azuma T Mol Immunol; 2006 Apr; 43(11):1751-60. PubMed ID: 16406527 [TBL] [Abstract][Full Text] [Related]
49. A universal combinatorial design of antibody framework to graft distinct CDR sequences: a bioinformatics approach. Haidar JN; Yuan QA; Zeng L; Snavely M; Luna X; Zhang H; Zhu W; Ludwig DL; Zhu Z Proteins; 2012 Mar; 80(3):896-912. PubMed ID: 22180101 [TBL] [Abstract][Full Text] [Related]
50. Comprehensive interrogation of a minimalist synthetic CDR-H3 library and its ability to generate antibodies with therapeutic potential. Mahon CM; Lambert MA; Glanville J; Wade JM; Fennell BJ; Krebs MR; Armellino D; Yang S; Liu X; O'Sullivan CM; Autin B; Oficjalska K; Bloom L; Paulsen J; Gill D; Damelin M; Cunningham O; Finlay WJ J Mol Biol; 2013 May; 425(10):1712-30. PubMed ID: 23429058 [TBL] [Abstract][Full Text] [Related]
51. Water channel in the binding site of a high affinity anti-methotrexate antibody. Gayda S; Longenecker KL; Manoj S; Judge RA; Saldana SC; Ruan Q; Swift KM; Tetin SY Biochemistry; 2014 Jun; 53(23):3719-26. PubMed ID: 24832237 [TBL] [Abstract][Full Text] [Related]
52. Designed Loop Extension Followed by Combinatorial Screening Confers High Specificity to a Broad Matrix MetalloproteinaseInhibitor. Bonadio A; Wenig BL; Hockla A; Radisky ES; Shifman JM J Mol Biol; 2023 Jul; 435(13):168095. PubMed ID: 37068580 [TBL] [Abstract][Full Text] [Related]
53. Neutralization of NGF-TrkA receptor interaction by the novel antagonistic anti-TrkA monoclonal antibody MNAC13: a structural insight. Covaceuszach S; Cattaneo A; Lamba D Proteins; 2005 Feb; 58(3):717-27. PubMed ID: 15625712 [TBL] [Abstract][Full Text] [Related]
54. Augmented Binary Substitution: Single-pass CDR germ-lining and stabilization of therapeutic antibodies. Townsend S; Fennell BJ; Apgar JR; Lambert M; McDonnell B; Grant J; Wade J; Franklin E; Foy N; Ní Shúilleabháin D; Fields C; Darmanin-Sheehan A; King A; Paulsen JE; Hickling TP; Tchistiakova L; Cunningham O; Finlay WJ Proc Natl Acad Sci U S A; 2015 Dec; 112(50):15354-9. PubMed ID: 26621728 [TBL] [Abstract][Full Text] [Related]
55. A monoclonal antibody inhibits gelatinase B/MMP-9 by selective binding to part of the catalytic domain and not to the fibronectin or zinc binding domains. Martens E; Leyssen A; Van Aelst I; Fiten P; Piccard H; Hu J; Descamps FJ; Van den Steen PE; Proost P; Van Damme J; Liuzzi GM; Riccio P; Polverini E; Opdenakker G Biochim Biophys Acta; 2007 Feb; 1770(2):178-86. PubMed ID: 17137715 [TBL] [Abstract][Full Text] [Related]
56. Structural basis for the binding of an anti-cytochrome c antibody to its antigen: crystal structures of FabE8-cytochrome c complex to 1.8 A resolution and FabE8 to 2.26 A resolution. Mylvaganam SE; Paterson Y; Getzoff ED J Mol Biol; 1998 Aug; 281(2):301-22. PubMed ID: 9698550 [TBL] [Abstract][Full Text] [Related]
57. Reconstitution of an Anti-HER2 Antibody Paratope by Grafting Dual CDR-Derived Peptides onto a Small Protein Scaffold. See K; Kadonosono T; Ota Y; Miyamoto K; Yimchuen W; Kizaka-Kondoh S Biotechnol J; 2020 Dec; 15(12):e2000078. PubMed ID: 32975036 [TBL] [Abstract][Full Text] [Related]
58. Hydroxamate-based peptide inhibitors of matrix metalloprotease 2. Jani M; Tordai H; Trexler M; Bányai L; Patthy L Biochimie; 2005; 87(3-4):385-92. PubMed ID: 15781326 [TBL] [Abstract][Full Text] [Related]
59. Structural mimicry of CD4 by a cross-reactive HIV-1 neutralizing antibody with CDR-H2 and H3 containing unique motifs. Prabakaran P; Gan J; Wu YQ; Zhang MY; Dimitrov DS; Ji X J Mol Biol; 2006 Mar; 357(1):82-99. PubMed ID: 16426633 [TBL] [Abstract][Full Text] [Related]
60. Building novel binding ligands to B7.1 and B7.2 based on human antibody single variable light chain domains. van den Beucken T; van Neer N; Sablon E; Desmet J; Celis L; Hoogenboom HR; Hufton SE J Mol Biol; 2001 Jul; 310(3):591-601. PubMed ID: 11439026 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]